US2004187865A1PendingUtilityA1
Metered dose inhaler for fluticasone propionate
Est. expiryApr 14, 2015(expired)· nominal 20-yr term from priority
A61M 2205/0222A61M 15/009A61P 11/00B65D 83/52A61M 15/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising fluticasone propionate or a physiologically acceptable solvate thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
Claims
exact text as granted — not AI-modified1 - 22 . (CANCELED)
23 . A process for manufacturing a metered dose inhaler for dispensing an inhalation drug formulation comprising a drug and a fluorocarbon propellant, comprising:
providing a metered dose inhaler can having a mouth, a cap for covering the mouth of said can, and a drug metering valve; applying to at least one internal surface of said can, cap or drug metering valve which comes into contact with said inhalation drug formulation, without prior application of a primer thereto, a fluorocarbon polymer, optionally in combination with one or more non-fluorocarbon polymers, to form a coating on said at least one internal surface of said can, cap or drug metering valve; and assembling said can, cap and drug metering valve into a completed metered dose inhaler.
24 . The process according to claim 23 , and further comprising the step of introducing into said metered dose inhaler said drug formulation.
25 . The process according to claim 24 , wherein said drug formulation is introduced into said can through said valve.
26 . The process according to claim 23 , wherein said fluorocarbon polymer is applied to said cap.
27 . The process according to claim 23 , wherein said fluorocarbon polymer is applied to said valve.
28 . The process according to claim 23 , wherein said fluorocarbon polymer is applied as a coating to an internal surface of said can and said coating is thereafter cured at an elevated temperature.
29 . The process according to claim 28 , wherein said can is formed of strengthened aluminum or an aluminum alloy.
30 . The process according to claim 28 , wherein said fluorocarbon polymer is applied to an internal surface of said can at a thickness of 1 μm to 1 mm.
31 . A process for manufacturing a metered dose inhaler for dispensing an inhalation drug formulation comprising a drug and a fluorocarbon propellant, comprising:
providing a metered dose inhaler can having a mouth, a cap for covering the mouth of said can, and a drug metering valve; applying to an internal surface of said can, which comes into contact with said inhalation drug formulation, a fluorocarbon polymer, optionally in combination with one or more non-fluorocarbon polymers, to form a coating on said internal surface of said can; and assembling said can, cap and drug metering valve into a completed metered dose inhaler, wherein said coating has a thickness of 1 μm to 100 μm.
32 . The process according to claim 31 , wherein said coating has a thickness of 1 μm to 25 μm.
33 . The process according to claim 31 , wherein a primer is applied to said can before application of said fluorocarbon coating.
34 . The process according to claim 31 , wherein said fluorocarbon polymer is applied to said can without prior application of a primer.
35 . The process according to claim 23 , wherein said fluorocarbon polymer is applied to said can by electrostatic dry powder coating.
36 . The process according to claim 23 , wherein said fluorocarbon polymer is applied to said can by spraying a preformed metered dose inhaler can inside with said fluorocarbon polymer and then curing at an elevated temperature.
37 . The process according to claim 36 , wherein curing is conducted at a temperature of 300° C. to 400° C.
38 . The process according to claim 36 , wherein curing is conducted at a temperature of 350° C. to 380° C.
39 . The process according to claim 23 , wherein said fluorocarbon polymer is coated on said can by in situ plasma polymerization at the can walls using fluorocarbon monomer.
40 . The process according to claim 39 , wherein plasma polymerization is conducted at a temperature of 20° C. to 100° C.
41 . A process according to claim 24 , wherein the fluorocarbon propellant is 1,1,1,2-tetrafluoroethane, or 1,1,1,2,3,3,3-heptafluoro-n-propane or mixtures thereof.
42 . A process according to claim 24 , wherein the fluorocarbon propellant is 1,1,1,2-tetrafluoroethane.
43 . A process according to claim 23 , wherein said can is made of metal wherein part or all of the internal metallic surfaces of the can are coated.
44 . A process according to claim 43 , wherein the metal is aluminium or an alloy thereof.
45 . A process according to claim 23 , wherein said fluorocarbon polymer is a perfluorocarbon polymer.
46 . A process according to claim 45 , wherein said fluorocarbon polymer is selected from PTFE, PFA, FEP and mixtures thereof.
47 . A process according to claim 24 , further comprising fitting said metered dose inhaler into a suitable channeling device for oral or nasal inhalation of the drug formulation.
48 . The process of claim 23 , wherein said can comprises side walls and a base of a thickness greater than 0.46 mm and said fluorocarbon polymer is applied to said can.
49 . A process for manufacturing a metered dose inhaler having internal metallic surfaces for dispensing an inhalation drug formulation comprising a particulate drug and a fluorocarbon propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoro-n-propane and mixtures thereof, comprising:
providing a metered dose inhaler can having a mouth, a cap for covering the mouth of said can, and a drug metering valve, wherein said can comprises side walls and a base having a thickness greater than 0.46 mm; forming a coating from a polymer composition comprising one or more fluorocarbon polymers on at least one of said internal metallic surfaces which comes into contact with said inhalation drug formulation without prior application of a primer thereto; and assembling said can, cap and drug metering valve into a completed metered dose inhaler.
50 . The process according to claim 49 , and further comprising the step of introducing into said metered dose inhaler said drug formulation.
51 . The process according to claim 49 , wherein said fluorocarbon polymer is applied to said cap.
52 . The process according to claim 49 , wherein said fluorocarbon polymer is applied to said valve.
53 . The process according to claim 49 , wherein said fluorocarbon polymer is applied as a coating to an internal surface of said can and said coating is thereafter cured at an elevated temperature.
54 . The process according to claim 49 , wherein said fluorocarbon polymer is applied to said can by spraying a preformed metered dose inhaler can inside with said fluorocarbon polymer and then curing at an elevated temperature.
55 . The process according to claim 54 , wherein curing is conducted at a temperature of 300° C. to 400° C.
56 . The process according to claim 54 , wherein said coating has a thickness of 1 μm to 1 mm.
57 . The process according to claim 54 , wherein said coating has a thickness of 1 μm to 100 μm.
58 . The process according to claim 54 , wherein said coating has a thickness of 1 μm to 25 μm.
59 . The process according to claim 23 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.
60 . The process according to claim 28 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.
61 . The process according to claim 31 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.
62 . The process according to claim 43 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.
63 . The process according to claim 49 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.
64 . The process according to claim 53 , wherein said fluorocarbon polymer is applied as a part of a polymer composition comprising said fluorocarbon polymer and a non-fluorocarbon polymer.Join the waitlist — get patent alerts
Track US2004187865A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.